Immunotoxic effects of engineered nanoparticles used inthe Australian workplace

  • Turney, Terence (Primary Chief Investigator (PCI))
  • Lopata, Andreas (Chief Investigator (CI))
  • Piva, Terrence (Chief Investigator (CI))
  • Wright, Paul (Chief Investigator (CI))

    Project: Research

    StatusFinished
    Effective start/end date1/01/1031/12/12

    Funding

    • National Health & Medical Research Council (NHMRC): AUD72,375.00